Clinical Trial: Combined Use of Machine Learning and Metabolomics to Improve the Diagnosis and Management of Hyperandrogenism

U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07253454) titled 'Combined Use of Machine Learning and Metabolomics to Improve the Diagnosis and Management of Hyperandrogenism' on Nov. 19.

Brief Summary: Hyperandrogenism is a common reason for consultation, the causes of which can range from common conditions (PCOS) to rarer conditions with major genetic implications (NC21OHD). It is characterized by elevated levels of circulating androgens, mainly testosterone. This excess of androgens usually manifests clinically as increased male-pattern hair growth and, less specifically, acne and alopecia. Its prevalence is estimated at between 6 and 12% in women of reproductive age, and its incidence is incr...